300238 冠昊生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.7674.3775.1596.165-48.504
总资产报酬率 ROA (%)1.2753.1193.8274.597-34.802
投入资产回报率 ROIC (%)1.3613.4264.2565.169-39.419

边际利润分析
销售毛利率 (%)76.64277.13279.46279.12676.246
营业利润率 (%)11.4527.8547.4828.409-77.406
息税前利润/营业总收入 (%)11.9937.9087.7849.263-76.086
净利润/营业总收入 (%)7.7083.8144.4005.214-86.841

收益指标分析
经营活动净收益/利润总额(%)91.167106.768151.827136.150-5.834
价值变动净收益/利润总额(%)-1.4566.9452.164-11.3443.760
营业外收支净额/利润总额(%)-1.785-11.631-0.801-5.9190.185

偿债能力分析
流动比率 (X)2.0041.7271.4931.5471.582
速动比率 (X)1.5421.3151.0521.1331.255
资产负债率 (%)37.13339.51738.01832.76435.706
带息债务/全部投入资本 (%)20.13018.85616.1857.29610.371
股东权益/带息债务 (%)380.082411.380488.3091,184.959783.020
股东权益/负债合计 (%)198.456178.864189.102234.149202.793
利息保障倍数 (X)16.1619.06421.5416.999-51.983

营运能力分析
应收账款周转天数 (天)54.66651.99157.54959.28485.248
存货周转天数 (天)306.595317.018348.411284.357406.164